REPORT ID 5190

EMEA (Europe, Middle East and Africa) Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Report 2019

Publish Date
2019
Pages
113
Format
Electronic (PDF)

In this report, the EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Benign Prostatic Hyperplasia (BPH) Treatment Devices for these regions, from   2019 to 2025 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices market competition by top manufacturers/players, with Benign Prostatic Hyperplasia (BPH) Treatment Devices sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Endo International (US)
    Karl Storz (Germany)
    Medtronic (US)
    Siemens (Germany)
    Lumenis (Israel)
    Olympus (Japan)
    Urologix (US)
    NeoTract (US)
    Boston Scientific (US)
    Urotech (Germany)
    Toshiba (Japan)
    Baxter International (US)

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Laser Based Procedure
    Other Energy Based Procedure

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospitals
    Ambulatory Surgical Centers
    Specialty Clinics
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Benign Prostatic Hyperplasia (BPH) Treatment Devices Market  Report 2019
1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Overview
    1.1 Product Overview and Scope of Benign Prostatic Hyperplasia (BPH) Treatment Devices
    1.2 Classification of Benign Prostatic Hyperplasia (BPH) Treatment Devices
        1.2.1 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (Sales) Comparison by Type ( 2014-2024)
        1.2.2 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 Laser Based Procedure
        1.2.4 Other Energy Based Procedure
    1.3 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Market by Application/End Users
        1.3.1 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales (Volume) and Market Share Comparison by Application ( 2014-2024
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Centers
        1.3.4 Specialty Clinics
        1.3.5 Other
    1.4 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Market by Region
        1.4.1 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 Europe Status and Prospect ( 2014-2024)
        1.4.3 Middle East Status and Prospect ( 2014-2024)
        1.4.4 Africa Status and Prospect ( 2014-2024)
    1.5 EMEA Market Size (Value and Volume) of Benign Prostatic Hyperplasia (BPH) Treatment Devices ( 2014-2024)
        1.5.1 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate ( 2014-2024)
        1.5.2 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate ( 2014-2024)

2 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Competition by Players/Manufacturers
        2.1.1 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Market Share of Major Players ( 2014-2019)
        2.1.2 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Share by Players ( 2014-2019)
        2.1.3 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sale Price by Players ( 2014-2019)
    2.2 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume and Value) by Type/Product Category
        2.2.1 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Type ( 2014-2019)
        2.2.2 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Type ( 2014-2019)
        2.2.3 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sale Price by Type ( 2014-2019)
    2.3 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume) by Application
    2.4 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume and Value) by Region
        2.4.1 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Region ( 2014-2019)
        2.4.2 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Market Share by Region ( 2014-2019)
        2.4.3 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Price by Region ( 2014-2019)

3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Value ( 2014-2019)
        3.1.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Growth Rate ( 2014-2019)
        3.1.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate ( 2014-2019)
    3.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Type
    3.3 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Application
    3.4 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume by Countries ( 2014-2019)
        3.4.2 Europe Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Countries ( 2014-2019)
        3.4.3 Germany Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate ( 2014-2019)
        3.4.4 France Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate ( 2014-2019)
        3.4.5 UK Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate ( 2014-2019)
        3.4.6 Russia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate ( 2014-2019)
        3.4.7 Italy Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate ( 2014-2019)
        3.4.8 Benelux Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate ( 2014-2019)

4 Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Value ( 2014-2019)
        4.1.1 Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Growth Rate ( 2014-2019)
        4.1.2 Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate ( 2014-2019)
    4.2 Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Type
    4.3 Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Application
    4.4 Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume by Countries ( 2014-2019)
        4.4.2 Middle East Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Countries ( 2014-2019)
        4.4.3 Saudi Arabia Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate ( 2014-2019)
        4.4.4 Israel Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate ( 2014-2019)
        4.4.5 UAE Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate ( 2014-2019)
        4.4.6 Iran Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate ( 2014-2019)

5 Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Value ( 2014-2019)
        5.1.1 Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Growth Rate ( 2014-2019)
        5.1.2 Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate ( 2014-2019)
    5.2 Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Type
    5.3 Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Market Share by Application
    5.4 Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales Volume by Countries ( 2014-2019)
        5.4.2 Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue by Countries ( 2014-2019)
        5.4.3 South Africa Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate ( 2014-2019)
        5.4.4 Nigeria Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate ( 2014-2019)
        5.4.5 Egypt Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate ( 2014-2019)
        5.4.6 Algeria Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate ( 2014-2019)

6 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturers/Players Profiles and Sales Data
    6.1 Endo International (US)
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Endo International (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 Karl Storz (Germany)
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Karl Storz (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 Medtronic (US)
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Medtronic (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 Siemens (Germany)
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Siemens (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 Lumenis (Israel)
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Lumenis (Israel) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    6.6 Olympus (Japan)
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Olympus (Japan) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.6.4 Main Business/Business Overview
    6.7 Urologix (US)
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Urologix (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.7.4 Main Business/Business Overview
    6.8 NeoTract (US)
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 NeoTract (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.8.4 Main Business/Business Overview
    6.9 Boston Scientific (US)
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Boston Scientific (US) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.9.4 Main Business/Business Overview
    6.10 Urotech (Germany)
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Benign Prostatic Hyperplasia (BPH) Treatment Devices Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Urotech (Germany) Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.10.4 Main Business/Business Overview
    6.11 Toshiba (Japan)
    6.12 Baxter International (US)

7 Benign Prostatic Hyperplasia (BPH) Treatment Devices Manufacturing Cost Analysis
    7.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Benign Prostatic Hyperplasia (BPH) Treatment Devices

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Benign Prostatic Hyperplasia (BPH) Treatment Devices Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Benign Prostatic Hyperplasia (BPH) Treatment Devices Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Market Forecast ( 2019-2025)
    11.1 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales, Revenue and Price Forecast ( 2019-2025)
        11.1.1 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales and Growth Rate Forecast ( 2019-2025)
        11.1.2 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Revenue and Growth Rate Forecast ( 2019-2025)
        11.1.3 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Price and Trend Forecast ( 2019-2025)
    11.2 EMEA Benign Prostatic Hyperplasia (BPH) Treatment Devices Sales